WM-8014: Selective KAT6A/B Inhibitor in Epigenetic Research

Executive Summary: WM-8014 is a highly potent, reversible, and selective inhibitor of the histone acetyltransferases KAT6A (MOZ) and KAT6B (MORF), acting at nanomolar concentrations (IC₅₀ = 8 nM and 28 nM, respectively) and demonstrating competitive binding at the acetyl-CoA site (APExBIO). It induces cell cycle arrest and senescence via the p16^INK4A–p19^ARF pathway without general cytotoxicity, validated by transcriptomic and in vivo zebrafish studies (bioRxiv 2025). WM-8014 is highly soluble in DMSO (≥76.1 mg/mL), but sparingly soluble in water and insoluble in ethanol. Its application is primarily recommended for in vitro and zebrafish models due to high plasma-protein binding in mammals, with the derivative WM-1119 preferred for mouse studies. This article clarifies WM-8014’s mechanistic profile and delineates its optimal experimental contexts, while addressing common misconceptions and integration strategies for cell cycle and senescence assays.

Biological Rationale

Histone lysine acetyltransferases (KATs) such as KAT6A and KAT6B are critical regulators of chromatin structure and gene expression. Dysregulation of KAT6A/B activity is implicated in oncogenesis, cellular proliferation, and evasion of senescence. Targeting these enzymes with selective inhibitors enables fine-tuned modulation of transcriptional programs underlying cancer cell identity and resistance mechanisms (RESTRICT-seq study). WM-8014, developed and supplied by APExBIO, provides a tool for dissecting these pathways with high specificity, enabling researchers to probe the role of KAT6A/B in cell cycle arrest and epigenetic reprogramming.

Mechanism of Action of WM-8014

WM-8014 functions as a reversible, competitive inhibitor at the acetyl-CoA-binding site of the MYST domain of KAT6A (IC₅₀ 8 nM), KAT6B (28 nM), KAT5 (224 nM), and KAT7 (342 nM). The acyl sulfonyl hydrazide moiety of WM-8014 forms hydrogen bonds mimicking the diphosphate group of acetyl-CoA, directly blocking substrate access (APExBIO). By occupying this critical site, WM-8014 prevents histone lysine acetylation, leading to altered chromatin accessibility and transcriptional repression of proliferation-associated genes.

• Competitive inhibition at the acetyl-CoA site is confirmed by direct structural and biochemical assays (bioRxiv 2025).
• Reversibility allows for controlled washout and restoration of KAT6A/B function in experimental systems.
• Specificity for KAT6A/B reduces off-target effects compared to pan-KAT inhibitors.

Evidence & Benchmarks

• WM-8014 selectively inhibits KAT6A (IC₅₀ = 8 nM), KAT6B (28 nM), KAT5 (224 nM), and KAT7 (342 nM) in cell-free enzymatic assays (APExBIO).
• RNA-seq in mouse embryonic fibroblasts (MEFs) shows upregulation of Cdkn2a (p16^INK4A/p19^ARF) and downregulation of Cdc6 following WM-8014 treatment, supporting induction of senescence through established pathways (bioRxiv 2025).
• Zebrafish models of KRAS G12V-driven hepatocellular overproliferation exhibit a concentration-dependent reduction in liver volume and S-phase hepatocyte entry after WM-8014 exposure, while normal liver growth is unaffected (bioRxiv 2025).
• WM-8014 does not cause general cytotoxicity at effective concentrations, as confirmed by cell viability and proliferation assays (Solving Cell-Based Assay Challenges).
• WM-8014’s solubility profile supports robust in vitro dosing: highly soluble in DMSO (≥76.1 mg/mL), sparingly soluble in water (8–16 μM), and insoluble in ethanol (APExBIO).

Applications, Limits & Misconceptions

WM-8014 is optimal for studies of epigenetic regulation, cell cycle arrest, and oncogene-induced senescence in vitro and in zebrafish models. Its selectivity enables precise dissection of KAT6A/B function in cancer biology and drug target validation (Unraveling Epigenetic Drug Targets). This article extends prior analyses by integrating recent CRISPR-based screen data and clarifying in vivo limitations.

Common Pitfalls or Misconceptions

• Not suitable for in vivo mouse efficacy studies: High plasma-protein binding limits systemic exposure; use WM-1119 for rodent models (APExBIO).
• Not a pan-KAT inhibitor: Selectivity for KAT6A/B is >10-fold over KAT5, KAT7; off-target KAT inhibition is minimal at recommended concentrations.
• Not cytotoxic at effective doses: Induces senescence and cell cycle arrest without general cell death (Cell-Based Assay Challenges).
• Solubility limits in aqueous buffers: Use DMSO-based stock solutions for consistent dosing; aqueous solubility is ≤16 μM.
• Long-term solution storage discouraged: Store powder at –20°C; freshly prepare solutions for reproducibility (APExBIO).

Workflow Integration & Parameters

WM-8014 is best integrated into cell-based assays assessing cell cycle, proliferation, and senescence. For RNA-seq or qPCR experiments, treat cells with WM-8014 (final DMSO ≤0.1%) for 24–72 hours, then harvest for transcriptomic analysis. For zebrafish models, dose embryos or larvae at defined developmental stages and monitor liver volume and proliferation markers (bioRxiv 2025).

• Recommended working concentrations: 10–500 nM for in vitro assays.
• Stock preparation: Dissolve in DMSO at ≥10 mM, store aliquots at –20°C.
• Control for DMSO vehicle effects in all experimental arms.

For advanced guidance on protocol optimization and troubleshooting, see Solving Cell-Based Assay Challenges with WM-8014, which this article updates by integrating new CRISPR screen data and specificity insights.

Conclusion & Outlook

WM-8014 is a benchmark tool for interrogating selective histone acetyltransferase inhibition in cancer biology and epigenetic research. Its precise, reversible, and non-cytotoxic inhibition of KAT6A/B enables pathway-specific studies of cell cycle arrest and senescence. By clarifying optimal applications and boundaries, this article extends prior discussions (Precision Epigenetics) and positions WM-8014 as a preferred agent for in vitro mechanistic work, while guiding users on in vivo alternatives and experimental design best practices.

For further details or to purchase, visit the WM-8014 product page at APExBIO.